Wen Xu
Qingdao University(CN)The University of Queensland(AU)State Ethnic Affairs Commission(CN)Princess Alexandra Hospital(AU)Princess Alexandra Hospital(AU)Chinese PLA General Hospital(CN)Second Hospital of Shandong University(CN)Affiliated Hospital of Qingdao University(CN)PowerChina (China)(CN)Suzhou Traditional Chinese Medicine Hospital(CN)Powerchina Huadong Engineering Corporation (China)(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer-related Molecular Pathways, Immunotherapy and Immune Responses, Melanoma and MAPK Pathways
Most-Cited Works
- → Targeting PI3K/Akt signal transduction for cancer therapy(2021)1,665 cited
- → Advances in targeted therapy for esophageal cancer(2020)534 cited
- → Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment(2021)354 cited
- → Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma(2021)174 cited
- → Fabrication and electrochemical properties of carbon nanotube array electrode for supercapacitors(2004)170 cited
- → FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review(2007)121 cited